Crossmark

Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients

Crossref DOI link: https://doi.org/10.1186/s12888-019-2059-x

Published Online: 2019-02-21

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghaderi, Amir https://orcid.org/0000-0001-9193-6039
Banafshe, Hamid Reza

Mirhosseini, Naghmeh

Moradi, Mohamad

Karimi, Mohammad-Amin

Mehrzad, Fateme

Bahmani, Fereshteh

Asemi, Zatollah
License Information

Text and Data Mining valid from 2019-02-21
More Information

Article History

Received: 9 October 2018

Accepted: 13 February 2019

First Online: 21 February 2019

Ethics approval and consent to participate

: All approaches carried out in reports involving human subjects were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments. Study protocol was approved by the ethics committee at Kashan University of Medical Sciences (KAUMS) (No. IR.KAUMS.REC.1396.10). Informed consent was signed by all participants prior to the intervention.

: Not applicable.

: The authors declare that they have no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.